Ignite Creation Date:
2024-05-06 @ 7:12 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05924217
Status:
RECRUITING
Last Update Posted:
2024-01-31
First Post:
2023-06-12
Brief Title:
Gynecology Beyond Gender Cervical Cancer Screening in Transgender Men in France
Sponsor:
Centre Hospitalier Universitaire de Nīmes
Organization:
Centre Hospitalier Universitaire de Nīmes
Study Overview
Official Title:
Gynecology Beyond Gender Exploration and Identification of Potential Obstacles and Levers in France for Cervical Cancer Screening in Transgender Men by Conducting an Opinion Survey in a Specific Population
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GYDECAT
Brief Summary:
In France cervical cancer screening is the subject of a national screening programme organized for all asymptomatic individuals aged 25 to 65 years with a cervix The latter contributes greatly to the prevention and early treatment of this disease whose public health challenge is recognized worldwide
One of the objectives of this programme is to reduce inequalities in access Transgender men ie individuals assigned to the female gender at birth but identifying with the male gender are concerned by this screening as long as they still have a cervix according to the same modalities as for cisgender women
However they are often excluded from health care including organized screening programs Gender change in civil status is one of the obstacles
The provision of gynaecological care is sometimes inadequate The lack of knowledge of health professionals and the problems of discrimination that transgender people may face reduce the chances of having equitable access
This survey aims to explore the perception that transgender men have of cervical cancer screening and to identify the challenges they face the obstacles and the levers to access this prevention program
One of the objectives of this programme is to reduce inequalities in access Transgender men ie individuals assigned to the female gender at birth but identifying with the male gender are concerned by this screening as long as they still have a cervix according to the same modalities as for cisgender women
However they are often excluded from health care including organized screening programs Gender change in civil status is one of the obstacles
The provision of gynaecological care is sometimes inadequate The lack of knowledge of health professionals and the problems of discrimination that transgender people may face reduce the chances of having equitable access
This survey aims to explore the perception that transgender men have of cervical cancer screening and to identify the challenges they face the obstacles and the levers to access this prevention program
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None